GHK-Cu: Copper Peptide Research in Fibroblast and Tissue Models

What Is GHK-Cu?

GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring copper-binding tripeptide first identified in human plasma. It has been the subject of extensive preclinical research into its biological roles, particularly in fibroblast and tissue remodeling models.

Collagen and Extracellular Matrix Research

In vitro studies have investigated GHK-Cu for its effects on fibroblast activity, including collagen I, collagen III, and elastin gene expression. Research has demonstrated upregulation of genes associated with extracellular matrix (ECM) production and remodeling, including tissue inhibitors of metalloproteinases (TIMPs) and decorin.

Animal Wound Models

Preclinical research in animal wound models has examined GHK-Cu's effects on inflammation modulation, angiogenesis, fibroblast recruitment, and matrix deposition. Animal wound models have been used to investigate closure rates, tensile strength, and histological outcomes.

Antioxidant and Anti-Inflammatory Pathways

GHK-Cu has been investigated in cellular models for antioxidant properties, including superoxide dismutase (SOD) upregulation, iron chelation, and modulation of oxidative stress markers. Anti-inflammatory effects have been explored through measurement of cytokine production, NF-κB signaling, and inflammatory cell recruitment in preclinical models.

Research Applications

ROEHN supplies GHK-Cu for in vitro and preclinical tissue remodeling research.